Sunscreen TEAs Could Illuminate How Deadlines Influence FDA’s Process
This article was originally published in The Rose Sheet
Executive Summary
CHPA says FDA’s work on sunscreen TEAs under deadlines now in place will give an idea of what industry can expect from changes Congress imposed on FDA’s TEA process. But industry will not know whether introducing other new OTC ingredients is a smoother process under the new framework until FDA establishes and follows process deadlines for non-sunscreen categories.